Safe Parenteral Nutrition Prescribing and Order Review
June 2017 - Vol. 14 No. 6 - Page #2

Parenteral nutrition (PN), a complex prescription therapy, is designated a high-alert medication by the Institute for Safe Medication Practices (ISMP).1 Despite this classification, a recent PN use survey with gap analysis reported that only 56% of organizations have precautions in place to prevent errors and patient harm associated with PN.2 The American Society for Parenteral and Enteral Nutrition’s (ASPEN) Parenteral Nutrition Safety Consensus Recommendations address safety concerns throughout the PN process, including prescribing, order review and verification, compounding, and administration of PN.3 Compliance with the ASPEN recommendations is critical to prevent PN errors and avert the potential for patient harm throughout the PN process; thus, organizations must ensure they fully understand and implement the recommendations.

You've reached the limit of what you can see this month without logging in. Please log in or create a free account.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register: